Article (Published version) (438 Kb) - 
Limited access to UNIGE
Highlights
More informations
Scientific Article
unige:89616 
 |
Immunogenicity of anti-HLA antibodies in pancreas and islet transplantation |
|
| Authors | 
| |
| Published in | Cell Transplantation. 2016, vol. 25, p. 2041-2050 | |
| Abstract | The aim of the current study was to characterize the anti-HLA antibodies before and after pancreatic islet or pancreas transplantation. We assessed the risk of anti-donor specific antibody (DSA) sensitization in a single-center, retrospective clinical study at Geneva University Hospital. Data regarding clinical characteristics, graft outcome, HLA mismatch, donor HLA immunogenicity and anti-HLA antibody characteristic were collected. Between January 2008 and July 2014, 18 patients received islet transplants and 26 patients received a pancreas transplant. Eleven out of 18 patients (61.1%) in the islet group and 12 out of 26 patients (46.2%) in the pancreas group had anti-HLA antibodies. Six patients (33.3%) developed DSA against HLA of the islets and 10 patients (38.4%) developed DSA against HLA of the pancreas. Most of the DSA were at low level. Several parameters such as gender, number of transplantation, HLA mismatch, eplet mismatch and PIRCHE-II numbers, rejection and infection were analyzed. Only the number of PIRCHE-II was associated with the development of anti-HLA class II de novo DSA. Overall, the development of de novo DSA did not influence graft survival as estimated by insulin independence. Our results indicated that pre-transplant DSA at low levels, do not restrict islet or pancreas transplantation, especially islets transplantation (27.8% versus 15.4.%). de novo DSA do occur at a similar rate in both pancreas and islet transplant recipients mainly of class II and the immunogenicity of donor HLA is a parameter that should be taken into consideration. Low level DSA combined with an adequate immunosuppressive regimen and a close follow-up is acceptable in both pancreas and islet transplantation and are not associated with reduced graft survival or graft function. | |
| Identifiers | PMID: 27196533 | |
| Full text | ||
| Structures | ||
| Research groups | Insuffisance rénale chronique (941) Transplantation immunologie et osteoimmunologie (561) | |
| Citation (ISO format) | CHAIGNE, Benjamin et al. Immunogenicity of anti-HLA antibodies in pancreas and islet transplantation. In: Cell Transplantation, 2016, vol. 25, p. 2041-2050. https://archive-ouverte.unige.ch/unige:89616 |
191 hits 
3 downloads 
Contact an author
Update